ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Abstract: SA-PO406

Comparative Effectiveness in Removing Uremic Toxins Between Hemodialysis With Reuse and Single-Use Super High-Flux Dialyzer

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis


  • Prapunwatana, Piyapun, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand
  • Chariyavilaskul, Pajaree, Clinical Pharmacokinetics and Pharmacogenomics Research Unit, Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • Susantitaphong, Paweena, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand
  • Avihingsanon, Yingyos, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand
  • Eiam-Ong, Somchai, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand
  • Tiranathanagul, Khajohn, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand

Although hemodialysis (HD) with single use super high-flux dialyzer (SHF) provided comparable uremic toxin removing efficacy of both small (such as β2-microglobulin, β2M) and large (for example λ-free light chain, FLC) middle molecules to high volume post-dilution online hemodiafiltration, the single use SHF is expensive. The present study was conducted to compare uremic toxin removing effectiveness between HD with reuse SHF and single-use SHF.


In this single center prospective study, 5 stable thrice-a-week HD patients underwent 3 periods of HD with reuse SHF dialyzer (ELISIO-21 HX), reprocessed with peracetic acid. In each period, one SHF dialyzer was maximally reused for 15 times and each patient utilized 2-4 SHF dialyzers for the whole study. The RR values of β2M and λ-FLC were compared between the 1st use and the 2nd, 5th, 10th, and 15th use. The 1st use of each SHF dialyzer was utilized to represent the single-use SHF dialyzer. Dialysate albumin lost and serum albumin were assessed.


A total of 15 dialyzers were analyzed. The RR of β2M (should be ≥ 80%) was comparable between the 1st use and 15th use (85.5 ± 5.9% vs 82.5 ± 3.5%). The λ-FLC RR (should be ≥ 40%) was 50.4 ± 4.9% at the 1st use which was significantly dropped to 40.0 ± 5.8% and 32.3 ± 5.5% at the 5th and 15th use, respectively (p < 0.001). Dialysate albumin loss was significantly decreased from 1.01 g at the 1st use to 0.19 and 0.06 g at the 2nd and 5th use and undetectable after the 10th use. No statistically significant changes in serum albumin and Kt/V were found.


HD with reuse SHF dialyzer provided comparable ability to remove β2M to single use SHF while the effectiveness in removing λ-FLC was gradually reduced after reuse. The removal of λ-FLC in the 5th use SHF was still comparable to high-volume online HDF. In conclusion, HD with reuse SHF dialyzer reprocessed with peracetic acid can be an alternative method to single use SHF with similar efficacy to high-volume online HDF at the 5th use.


  • Private Foundation Support